David C. Mun-Gavin
Director · GT Biopharma, Inc.
Individual
- 2025
- Sep 4, 2025
- 1
Filings (90d)
Other insiders active in the same sector
No other insider has filed at David C. Mun-Gavin's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- RA CAPITAL MANAGEMENT, L.P. - $59.04M in SGP purchases and sales in the last 12 months
- Mark A. Goldsmith - $55.93M in RVMD purchases and sales in the last 12 months
- ORBIMED ADVISORS LLC - $55.67M in SION purchases and sales in the last 12 months
- Peter A. Thompson - $55.67M in SION purchases and sales in the last 12 months
- John E. Kao - $54.16M in ALHC purchases and sales in the last 12 months
- Mahkam Zanganeh - $51.45M in SMMT purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is David C. Mun-Gavin?
David C. Mun-Gavin is a corporate insider, tracked as Director of GT Biopharma, Inc. (GTBP). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did David C. Mun-Gavin last file a Form 4?
The only primary Form 4 on record is dated 4 September 2025.